## **What is golimumab (IV) injection?**
HCPCS code J1602 refers to injection golimumab 1mg for intravenous use, a biological drug marketed as Simponi Aria. This specific code is assigned for billing when the medication is administered via intravenous infusion, typically under the supervision of a healthcare provider in a clinical setting.
Golimumab is FDA-approved for the treatment of several chronic inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, ulcerative colitis, and Crohn's disease.
Golimumab works by targeting tumor necrosis factor (TNF), reducing inflammation and improving symptoms such as pain and swelling. It is often used when patients have had an inadequate response to non-biologic DMARDS or other therapies. Unlike the subcutaneous injection form of golimumab, HCPCS code J1602 applies specifically to the intravenous form and is billed per 1 mg.
Correct coding ensures accurate reimbursement, supports coverage under Medicare and private payers, and helps healthcare providers meet documentation and billing unit requirements maintained by CMS.
## **J1602 documentation requirements**
For HCPCS code J1602 (injection golimumab 1 mg for intravenous use), documentation must confirm the patient’s diagnosis, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, ulcerative colitis, or Crohn’s disease, and the medical necessity for intravenous infusion. Records should specify the total billing unit in mg, diagnostic injection, dose administered, and the administration method.
The healthcare provider must note any relevant symptoms, treatment response, and risks such as serious infections. The documentation should also align with CMS and payer guidelines to ensure accurate billing, reimbursement, and coverage for this drug.
## **J1602 billing requirements**
When billing for HCPCS code J1602, providers should follow these best practices:
- Use the correct code and billing units: Assign J1602 from the CMS all-inclusive list for drugs administered by intravenous infusion, and bill based on the total milligrams administered. Each 1 mg equals one billing unit. For example, a 50 mg dose requires 50 billing units.
- Support medical necessity: Ensure claims document that treatment is for conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, ulcerative colitis, or Crohn’s disease, and confirm that the intravenous infusion of golimumab was medically appropriate.
- Include administration details: Record the total dose administered, intravenous use specifications, and infusion specifics to align with payer expectations.
- Separate infusion services: If using an IV setup or infusion administration, include relevant CPT codes like 96365 to reflect the therapeutic or diagnostic infusion service.
- Prevent errors in billing: Over- or under-reporting doses can lead to claim denials or reimbursement delays. Precision in documenting "dose administered" and prorating billing units is critical.
- Align with CMS and payer policies: Verify coverage, especially for use of Simponi Aria®, and adhere to Medicare guidelines on reimbursement, prior authorization, and drug-specific billing expectations.
## **Other relevant codes**
- J1600 – Injection, gold sodium thiomalate, up to 50 mg
- J1610 – Injection, glucagon hydrochloride, per 1 mg
Frequently asked questions
